Allianz Asset Management
AVNS

Allianz Asset Management’s Avanos Medical AVNS Stock Holding History

Allianz Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.72M Buy
265,572
+124,203
+88% +$1.67M ﹤0.01% 1300
2025
Q4 		$1.59M Buy
141,369
+81,834
+137% +$936K ﹤0.01% 1615
2025
Q3 		$688K Buy
59,535
+17,802
+43% +$208K ﹤0.01% 1785
2025
Q2 		$511K Buy
+41,733
New +$525K ﹤0.01% 1827
2024
Q4 		– Sell
-13,300
Closed -$320K – 2210
2024
Q3 		$320K Sell
13,300
-17,400
-57% -$398K ﹤0.01% 1975
2024
Q2 		$612K Hold
30,700
– – ﹤0.01% 1769
2024
Q1 		$611K Hold
30,700
– – ﹤0.01% 1558
2023
Q4 		$689K Hold
30,700
– – ﹤0.01% 1746
2023
Q3 		$621K Hold
30,700
– – ﹤0.01% 1854
2023
Q2 		$785K Buy
+30,700
New +$809K ﹤0.01% 1616
2019
Q1 		– Sell
-143,608
Closed -$6.43M – 2666
2018
Q4 		$6.43M Sell
143,608
-154,111
-52% -$8.07M 0.01% 1309
2018
Q3 		$20.4M Sell
297,719
-77,966
-21% -$5.02M 0.02% 883
2018
Q2 		$21.5M Buy
375,685
+184,235
+96% +$9.74M 0.02% 839
2018
Q1 		$8.82M Buy
191,450
+33,242
+21% +$1.58M 0.01% 1306
2017
Q4 		$7.31M Buy
158,208
+104,386
+194% +$4.8M 0.01% 1471
2017
Q3 		$2.42M Buy
53,822
+1,360
+3% +$58K ﹤0.01% 1938
2017
Q2 		$2.06M Sell
52,462
-1,805
-3% -$68.2K ﹤0.01% 1972
2017
Q1 		$2.07M Buy
54,267
+13,825
+34% +$539K ﹤0.01% 1982
2016
Q4 		$1.5M Buy
40,442
+20,400
+102% +$729K ﹤0.01% 2074
2016
Q3 		$694K Buy
+20,042
New +$702K ﹤0.01% 2303
2015
Q4 		– Sell
-11,897
Closed -$338K – 2442
2015
Q3 		$338K Sell
11,897
-11,042
-48% -$385K ﹤0.01% 2167
2015
Q2 		$929K Buy
22,939
+1,557
+7% +$69.9K ﹤0.01% 1984
2015
Q1 		$1.05M Sell
21,382
-7,913
-27% -$367K ﹤0.01% 1767
2014
Q4 		$1.33M Buy
+29,295
New +$1.15M ﹤0.01% 1724

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Allianz Asset Management's AVNS Position: Q1 2026 in Review

Allianz Asset Management increased its Avanos Medical (AVNS) stake by 88% in Q1 2026, buying an estimated $1.67M and bringing the position to 265,572 shares worth $3.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Allianz Asset Management first reported a position in AVNS in Q4 2014 and has held it in 24 quarters since. The position peaked at $21.5M in Q2 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Allianz Asset Management held 265,572 shares of Avanos Medical worth $3.72M as of Q1 2026.
  • Allianz Asset Management bought 124,203 Avanos Medical shares in Q1 2026, an estimated $1.67M.
  • Avanos Medical made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1300 holding.
  • Allianz Asset Management first reported a position in Avanos Medical in Q4 2014 and has held it in 24 quarters since.
  • Allianz Asset Management's Avanos Medical position peaked at $21.5M in Q2 2018.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.